Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NGNENGNE
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NEUROGENE INC

CITADEL ADVISORS LLC holds 408,982 shares of NGNE (NEUROGENE INC), worth $12.9M as of 2026-Q2. The position was increased (+5.7% shares). NGNE represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$12.9M

Current Shares

408,982

Total Value Change

+$12.7M

Total Shares Change

+392,566

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
408,982
+5.7%
$12.9M0.0%$31.45
30
2026-Q1
Increased
387,031
+6.3%
$7.8M0.0%$21.99
29
2025-Q4
New
364,228
-
$7.5M0.0%$22.11
38
2025-Q2
Exited
0
-100.0%
$00.0%$16.16
0
2025-Q1
New
16,416
-
$192,2310.0%$14.52
35

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used